Sina Beer

9PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumoursMajor global burdens of diseaseTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 24, 2026
Induction intensity in transplant-eligible primary CNS lymphoma: no survival benefit despite increased toxicity.

|Aug 20, 2025
Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Sina A Beer, David A Cairns, Charlotte Pawlyn

|Apr 08, 2025
Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy.

Sina A Beer, Molly Went, Charlie Mills

|Feb 26, 2025
Long-term patient-reported outcomes following allogeneic hematopoietic cell transplantation.

Sina Alexandra Beer, Johanna Blättel, Kristina Reuß

|Aug 09, 2024
Clinical relevance of brain MRI changes in primary central nervous system lymphoma after high-dose-chemotherapy and autologous stem cell transplantation.

Sina A Beer, Robert Möhle, Ghazaleh Tabatabai

|Jun 19, 2024
Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre-B acute lymphoblastic leukemia.

Sina A Beer, Wolfgang Bethge, Christoph Faul

Pageof 2

Frequent Collaborators

3 joint publications

Martin Kaiser

3 joint publications

Dimitrios Mougiakakos

2 joint publications

Jessica Schneider

2 joint publications

Claudia Lengerke